ࡱ>     _ ?bjbj |bb6vv4hlLd"(<"<"<"p#R%%H$@&&p#p#&&&&<"<"4.+.+.+&&R<"<".+&&.+.+frpcy<"x&v3uDm҄0wu&&&cycyF&z &&&&.+&&&&&&&&&&(&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&v :  Investigator Manual Revised August 22, 2016 Table of Contents  TOC \o "1-3" \h \z \u  HYPERLINK \l "_Toc366438825" What is the purpose of this manual?  PAGEREF _Toc366438825 \h 3  HYPERLINK \l "_Toc366438826" What is Human Research?  PAGEREF _Toc366438826 \h 3  HYPERLINK \l "_Toc366438827" What is the Human Research Protection Program?  PAGEREF _Toc366438827 \h 3  HYPERLINK \l "_Toc366438828" What training does my staff and I need to conduct human research?  PAGEREF _Toc366438828 \h 3  HYPERLINK \l "_Toc366438829" What are the obligations of individuals who conduct human research?  PAGEREF _Toc366438829 \h 4  HYPERLINK \l "_Toc366438830" How do I submit new human research to the IRB?  PAGEREF _Toc366438830 \h 4  HYPERLINK \l "_Toc366438831" How do I write an Investigator Protocol?  PAGEREF _Toc366438831 \h 4  HYPERLINK \l "_Toc366438832" How do I create a consent document?  PAGEREF _Toc366438832 \h 4  HYPERLINK \l "_Toc366438833" What are the different regulatory classifications that research activities may fall under?  PAGEREF _Toc366438833 \h 5  HYPERLINK \l "_Toc366438834" What are the decisions the IRB can make when reviewing proposed research?  PAGEREF _Toc366438834 \h 5  HYPERLINK \l "_Toc366438835" How does the IRB decide whether to approve human research?  PAGEREF _Toc366438835 \h 6  HYPERLINK \l "_Toc366438836" What will happen after IRB review?  PAGEREF _Toc366438836 \h 6  HYPERLINK \l "_Toc366438837" How do I submit continuing review?  PAGEREF _Toc366438837 \h 6  HYPERLINK \l "_Toc366438838" How do I submit a modification?  PAGEREF _Toc366438838 \h 7  HYPERLINK \l "_Toc366438839" How do I close out a study?  PAGEREF _Toc366438839 \h 7  HYPERLINK \l "_Toc366438840" How long do I keep records?  PAGEREF _Toc366438840 \h 7  HYPERLINK \l "_Toc366438841" How do I get additional information and answers to questions?  PAGEREF _Toc366438841 \h 7  What is the purpose of this manual? This document is designed to guide you through policies and procedures related to the conduct of human research that are specific to this organization. General information regarding human research protections and relevant federal regulations and guidance is incorporated into the required human protections training. For additional information see below:  HYPERLINK \l "_What_training_does" What training does my staff and I need in order to conduct human research? What is Human Research? POLICY: Human Research Protection Program (HRP-010) defines the activities that this organization considers to be Human Research. An algorithm for determining whether an activity is human research can be found in the WORKSHEET: Human Research (HRP-421). Use this document for guidance, keeping in mind that the IRB makes the ultimate determination in questionable cases as to whether an activity constitutes human research subject to IRB oversight. You are responsible not to conduct human research without prior IRB review and approval. If you have questions about whether an activity is human research, contact the IRB Office who will provide you with a determination. If you wish to have a written determination, provide a written request to the IRB Office. If you have questions about whether an activity requires IRB review, contact the IRB Office. What is the Human Research Protection Program? A Human Research Protection Program or HRPP is an organization-wide system to protect human subjects in research. It is described in POLICY: Human Research Protection Program (HRP-010). What training does my staff and I need to conduct human research? All members of the research team involved in the design, conduct, or reporting of the research must complete training. Investigators and staff conducting research involving more than minimal risk to subjects must complete the Collaborative Institutional Training Initiative (CITI) human subjects online training program. Investigators and staff conducting research involving no more than minimal risk to subjects must complete either the online CITI program or the National Institutes of Health (NIH) Protection Human Research Participants Course (PHRP). The CITI site can be accessed at  HYPERLINK "http://www.citiprogram.org/" http://www.citiprogram.org/. The NIH PHRP site can be accessed at  HYPERLINK "http://phrp.nihtraining.com/users/login.php" http://phrp.nihtraining.com/users/login.php. On a case-by-case basis, the IRB can approve alternative training. Training is valid for a three-year period, after which time the training must be repeated. This section describes the training requirements imposed by the IRB. You may have additional training imposed by other federal, state, or organizational policies. Members of the research team who have not completed human research protections training may not take part in aspects of the research that involve human subjects. What are the obligations of individuals who conduct human research? The obligations of individuals who conduct human research can be found in these documents: INVESTIGATOR GUIDANCE - Investigator Obligations (HRP-800) INVESTIGATOR GUIDANCE - Prompt Reporting Requirements (HRP-801) INVESTIGATOR GUIDANCE - Informed Consent (HRP-802) INVESTIGATOR GUIDANCE - Documentation of Informed Consent (HRP-803) INVESTIGATOR GUIDANCE - Additional DOD Obligations (HRP-810) INVESTIGATOR GUIDANCE - Additional DOE Obligations (HRP-811) INVESTIGATOR GUIDANCE - Additional DOJ Obligations (HRP-812) INVESTIGATOR GUIDANCE - Additional ED Obligations (HRP-813) INVESTIGATOR GUIDANCE - Additional EPA Obligations (HRP-814) INVESTIGATOR GUIDANCE - Additional FDA Obligations (HRP-815) INVESTIGATOR GUIDANCE - Additional ICH-GCP Obligations (HRP-816) How do I submit new human research to the IRB? Complete the FORM: Initial Review (HRP-200), attach all requested documents, and provide to the IRB Office. Maintain electronic copies of all information submitted to the IRB in case revisions are required. How do I write an Investigator Protocol? You may use TEMPLATE PROTOCOL (HRP-503) as a starting point for drafting a new Investigator Protocol, and reference the instructions in italic text for the information the IRB looks for when reviewing research. You may use any format or style as long as the required information is included. How do I create a consent document? You may use TEMPLATE Consent (HRP-500) or TEMPLATE Consent for Minimal Risk Research (HRP-500) to create a consent document. You may use any format or style as long as the required information is included. Most consent documents, summaries, and consent scripts must include the required and additional appropriate disclosures in Section 4 of WORKSHEET: Criteria for Approval (HRP-400). Date the revisions of your consent documents to ensure that you use the most recent version approved by the IRB. What are the different regulatory classifications that research activities may fall under? Submitted activities may fall under one of the following four regulatory classifications: Not Human Research: Activities that do not meet the organizational definition of Human Research do not fall under IRB oversight. The criteria for whether an activity is human research is in WORKSHEET: Human Research (HRP-421) Contact the IRB Office in cases if you are uncertain whether an activity is human research. Human research that does not engage the institution: Some human research requires review by an IRB, but is not the responsibility of the organization. The criteria for this determination is in WORKSHEET: Engagement (HRP-422) Contact the IRB Office in cases if you are uncertain whether human research is the responsibility of the organization. Exempt: Certain categories of human research may be exempt from regulation but require IRB review. It is the responsibility of the organization, not the investigator, to determine whether human research is exempt from IRB review. WORKSHEET: Exemption (HRP-423) for the categories of research that may be exempt. Review Using the Expedited Procedure: Certain categories of human research are not exempt but may qualify for review using the expedited procedure, meaning that the project may be approved by a single designated IRB reviewer, rather than the convened board. Review the IRB Administrations WORKSHEET: Expedited Review (HRP-424) for the categories of research that may be reviewed using the expedited procedure. Review by the Convened IRB: Non-exempt human research that does not qualify for review using the expedited procedure must be reviewed by the convened IRB. What are the decisions the IRB can make when reviewing proposed research? The IRB may approve research, require modifications to the research to secure approval, table research, or disapprove research: Approve: Made when all criteria for approval are met. See How does the IRB decide whether to approve human research? below. Conditionally Approve: Made when IRB members require specific modifications to the research before approval can be finalized. The IRB describes the required modifications and their reasons, and gives the investigator an opportunity to respond to the IRB in person or in writing. Defer: Made when the IRB determines that the board is unable to approve research and the IRB suggests modifications the might make the research approvable. The IRB describes the recommended modifications and their reasons, and gives the investigator an opportunity to respond to the IRB in person or in writing. Disapprove: Made when the IRB determines that it is unable to approve research and the IRB cannot describe modifications the might make the research approvable. The IRB describes its reasons for this decision and gives the investigator an opportunity to respond to the IRB in person or in writing. How does the IRB decide whether to approve human research? The criteria for IRB approval for exempt research can be found in the WORKSHEET: Exemption (HRP-423) for exempt human research and for non-exempt research in WORKSHEET: Criteria for Approval (HRP-400). The latter worksheet references other checklists that might be relevant. All checklists and worksheets can be found on the IRB Web site. These checklists are used for initial review, continuing review, and review of modifications to previously approved human research. You are encouraged to use the checklists to write your protocol in a way that addresses the criteria for approval. What will happen after IRB review? The IRB will provide you with a written decision indicating that the IRB has approved the human research, requires modifications to secure approval, or has disapproved the human research. If the IRB has approved the human research: The human research may commence once all other organizational approvals have been met. IRB approval is usually good for a limited period of time which is noted in the approval letter. If the IRB conditionally approved your research and you accept the modifications: Make the requested modifications and submit them to the IRB. If all requested modifications are made, the IRB will issue a final approval. Research cannot commence until this final approval is received. If you do not accept the modifications, write up your response and submit it to the IRB. If the IRB deferred the human research: The IRB will provide a statement of the reasons for deferral and suggestions to make the study approvable, and give you an opportunity to respond in writing. In most cases if the IRBs reasons for the deferral are addressed in a modification, the human research can be approved If the IRB disapproved the human research: The IRB will provide a statement of the reasons for disapproval and give you an opportunity to respond in writing. In all cases, you have the right to address your concerns to the IRB directly at an IRB meeting. How do I submit continuing review? Complete the FORM: Continuing Review (HRP-202), attach all requested documents, and provide to the IRB Office. Maintain electronic copies of all information submitted to the IRB in case revisions are required. If the continuing review application is not received by the date requested in the approval letter, you will be restricted from submitting new human research until the completed application has been received. How do I submit a modification? Complete the FORM: Modification (HRP-203), attach all requested documents, and provide to the IRB Office. Maintain electronic copies of all information submitted to the IRB in case revisions are required. How do I close out a study? Complete the FORM: Continuing Review (HRP-202), attach all requested supplements, have the formed signed by the individuals listed in the form, and provide the requested number of copies to the IRB Office. Maintain electronic copies of all information submitted to the IRB in case revisions are required. If you fail to submit a continuing review form to close out human research, you will be restricted from submitting new human research until the completed application has been received. How long do I keep records? Maintain signed and dated consent documents for at least three years after completion of the research. Maintain signed and dated HIPAA authorizations and consent documents that include HIPAA authorizations for at least six years after completion of the research. If your human research is sponsored, funded, or FDA-regulated there may be additional requirements. Contact the sponsor, funding agency, or IRB for additional information. How do I get additional information and answers to questions? This document and the policies and procedures for the Human Research Protection Program are available on the IRB Web Site at http://research.utsa.edu/oric/irb/. You may contact the IRB Office at: IRB Office GSR 2.128C/D One UTSA Circle San Antonio TX 78249 (210) 458-6473 irb@utsa.edu     LOGOInvestigator ManualDocument No.:Effective Date:Page:HRP-80022 August 2016Page  PAGE \* Arabic \* MERGEFORMAT 6 of  NUMPAGES \* Arabic \* MERGEFORMAT 7 -.@AXYZ[wxyzųqeqOqAhO^hc9mHnHu*j8hO^hc90JUmHnHuhO^hc9mHnHuhO^hc90JmHnHu$jhO^hc90JUmHnHujhO^hU hO^hhr5CJOJQJ^JaJ#hO^h5CJOJQJ^JaJ#hO^h5CJ0OJQJ^JaJ0#hO^hc95CJ0OJQJ^JaJ0,jhO^hc95CJ0OJQJU^JaJ0.@   p s | Fd gd1gdK# $ gd* hO^hV hO^h1 hO^h/1_ hO^hvhO^h*>*󰿰w>* hO^hw hO^hqw hO^h?aDhO^h-c>* hO^h-c hO^hj hO^h* hO^h KA hO^h7'(((((()))g))))))*J******2+@+J+W+^+_+`+{+++`,a,f,g,,,,-------:.;...../0/E/Y/_/b/c/p/~/////ܾ hO^hqY hO^hV hO^h/1_ hO^h-H hO^h)VhO^h >*󰿰* hO^hSv hO^h-chO^h-c>* hO^hqw hO^hw hO^h33亳ȥȥȥp󰿰* hO^hK_ hO^hG hO^h hO^h-c>*󰿰w>*󰿰KC">* hO^hKC" hO^h-H hO^h. hO^hAM hO^hSv hO^hw hO^h{ hO^ht hO^ha hO^h)V hO^hV hO^h* hO^hw hO^hQ$ hO^h5hO^hw>*󰿰* hO^hu hO^h)V hO^h hO^hKC"hO^h >*/999999::;;>;;;;;<<<==N=O=== >,>->.>5>B>L>P>Q>V>\>>>>>>>>>>>>>>>>>ϺϮϮh5IMjh5IMU hO^hUChO^hO^mHnHuhO^hDtmHnHuhO^hc9mHnHu hO^h0 hO^hAM hO^h)+ hO^h1 hO^hw hO^h U hO^hQ>R>]>>>>>>>>>>>>>>>>> .$$Ifa$gdr $$Ifa$gdD$  & F^gdc9^gdc9gd>>>>>?????'?5?6?;?>>???xoccc /$$Ifa$gdr $IfgdD$kd$$IfTl40  t0m644 laf4ytrT???'?6??RI@7@ 0$Ifgdr 0$IfgdD$ $IfgdD$kd$$IfTl4\   q t0m644 laf4ytrTd?e?????????????ٽ hO^hUCh5IM h2h6h6hURsh6CJaJh ehrCJhrhr5CJOJQJ^J6jhr5B*CJOJQJU^JmHnHphu3hrhr5B*CJOJQJ^JmHnHphuhrjhrU ???????RMK<KK($ !%|)a$gd2gdURskd$$IfTl4{\   q t0m644 laf4ytrT??  & F^gdc99&P1h:p/ =!"#$%0 ?0P1h:pr/ =!"#$% Dp21h:pr/ =!8"8#$% 8DdP  C ,AUTSA Logobh ˣI4;pD| nhh ˣI4;PNG  IHDR sRGBgAMA a pHYsodtEXtSoftwareMicrosoft Office5qIDATx^]`TE wjw^F M*E@,QQATDl`AEbATHAzz9=@n6}of=ޙ\ C r) R0000ȥ0````Ka A.!\ C r) R0000ȥ0````Ka A.!\ C r) R0000ȥ0````Ka A.!\ C r) R0000ȥ0````Ka A.!\ C r) R0000ȥ0````Ka A.!\ C r) R0000ȥ0````Ka A.!\ C r) R0000ȥ0````Ka A.!\ C r) Rd2$[ل|W/|^~yvC@`Jwz)OKh,^Y ECP,Lpw!L^w ŭ5%4000Ƚ"x /Ò>}.<?o.+?```{uJ8m> !X]rf(ϠPъҽlOL㊈_$lmp9T.@0z?P͘Y.(7U@V-po٢HӪ% W URJGPYg6mg_ .GVpxu@@b/UEsoN1y-!IEe`ha7}>f/k~ځ#Ο3y sM4DEQ@~_Fn^ݲ%(T&σʣxu; prsjH a]%ұ %nlQċǡ"ygBAy"H '`+QDKSӈI'K/xE$ʽPXt=Ͼ96  r =]pkͰ0LDp =EJg!)KOZƟ~ۃ[jkM*I/am|ӈkG- <ӥ\Se s50&N‹oDٖՅ TB&o(pc~h}:fo #K 'aO ]Lz܋T {=j4.\8H*O|L!(R;iIZJXz{8>Rg2 05M3+D'Wpn[j&3F"%h(n{?^h.YNax euXWɿ'wh RvV~ObMW<7B§b_hMyހ֦Q;VZ= `8>'GGm%oI$bY吔ƞ6GSu8k||1lfXsd+dP+>Gb@%$bCoX*WdR 0i .+$ EréH@RO$(ǐ= j6,$ppDIԪoZ?v &EnGtL,k7Ģ19e7Ղ'h j\_͒(L۱hm:BŠ/V;|vGLܹ \[Q_*BWuF|_~FL)P;M~Ѻϣ {o ElavLwkiJ|s+l /NM$ wd@]_<"Z_ki׾|7<Z9+$$gm_Y0$g ؈\REÄuC*'5=*K̳}~)BO )\Y'FLżu Wjx j6dKq"(߄Rcꟑ_,,r=P,y $ T RҥH}J0E͎H:_\Y86RΜ&^pC($k[$!7`0TC-j`R^؇RCwB%O%MX(OB)qG򹛾Kia_v-z&O38T8Jޕ ZF'B݃TH`BaE<#!TQ+X]=J].~OZ$u'B\3j"Xڳ:nO!eC'`pi:؀c_KL_ʢ]=zZԤ L.JGߨ^n,|֜U;o d%A3s؏w?ÞFVɨ؁ݬnuçE?|??.z>[ J4iyˎJX!<<+ d57@ՔyoDt7ZĶʪ~9n(uYIDBwLXS3Du:1A%  A?;-A=1㕏кL^iY=?sKa[@hs^Јq"}W^ "{^ C%_-av@'b+ :_&3¿r87ƍrNED oG̾[O@swXZqPVwwٵ7ȉ8v4V}cg.DEYJ_ pɦC~BB*PHRewM\-};`dfXؽ~R"qE%V[4yeMe]QQpx 57*d[pO;P+x.32Z:BEe +T3yZ=*w\+ouAPXtD I wE578v ?%S@! 8}^ZZ{yMwי3Sl@0ԬwVvDXBa%T5p@+tӐٍ#ٚ-v?Ê"}U,ezx$w'`;SsQ|~T4S5] yM  Ћ7:pH,M[ P8 d`\Q!ՀIp9=n7yjdžmP9׺E6 A{=9:Y#C9/,\y6RL,z.B%>OOtx*D ׌wUc{qAY3( v#f[#2~Fq%;,Tv0ReRQL=$ N 偫jל1ǟqlqn؎ڈ,O_iä'aseO)/]e_nM;Gf,|: z" ߸ -wz$7Ћw$2A @ 1pY ׶~п'G#.g/Ζ+gb[Z:z;ah'd$˿m!,{L|z1:}5C&#pg{>Pp&|W3L72{Ѡtk9Jpx[3óNMm40-[FPN'\T'׺R ɺ>ddҦu?w%:z6n;M9!C_Q7lp]Y" pw0}F\#v cxvh3`7&S]pgGk?%~"3Ew.f'sF›Tҗ>_TűQ%PWXiLX>=mS.zrUDp}QV]z-u:wtDа |M%6sbn !-GUB~d zƭ{5?ejtU-ύ.91z4gaӺ(]&P$lds]T3;QZ4 Ab|?yIREIM`א2q8Z"$g\M}kr<8c7i.R+W/bE14́kn8~gj ŢNkB -nQ5jِzѲ61 =mc-C{<޴67AruDaX)`CՎ^R-/(JF]} w`M=dL^_*tV>A^C/}w>Y~݃CG(\CJ&]VOR:b? H`g4L7~5'0{}6}g >C(4TR?=9[FZGGT+V~(u*{*s oW_I^qEg-ut)GaOD4k^:>g$U#4a :sM c2\DV?yeqG(R1; KǴ(T՟İܬ߿*ziĈ񾱯jk-<ZtJ3,-me\Ps\6RK韝PӦVDʧ}4X{.\UoCYn0؄󄟉;"=Jݳ泾H9~9< =Cw_G|r(fU6wUTKG y7֍W<ֿ!GuLEZ]pGp\ܷӳݿ<3tϫN]ۮ9JQ d>i)!Es(BIχ1hkXbv A([*EhjqZTH7_61?D!;|$>zF|u#JHnRr5B2818f߭eX):".[ sxBa k߾u]qAM- :y uçf!ZϺP!x:U070xA"'n)p<H{\a8zCGL+xՃ'Khꂼ"bl2 \b kD]"BJYhN+?#J%|c ӠR| VV0 e+NM`nXLA;_TSj:92* ۍŐ_Ê?ˁ'z{J-ea;9B[M<եJV:VU iNHs5LO$<.Zir7Ir$Pہc_<; CbSQ^KyV!Klٔ"B(dh Ci.Cӌt&; ].~k%_&qL4VC]눲EOE<%{Jx'!__Öi:x.ӽLHiCha`?5\J@i,?s݀NBE Wץ|M(iyP';i3g=-~)McR&(θ:z*9kQ荻*E.wk!A]! KHY5l˄wNPB]^6@^\aL3/CDؿ.'%(||ҎW T^V?G6cP-xwf}f xl*&S*+WӲ%6=F)?#5ѥ=|ݺ.2C'5'<СeV'U?AmzA"0<+rpH_X/:qD/!s҈zy_iI_J!v:r}iC 9::;3f&MfKNigQHv\ᙕ2Ű_ELlk˳ryע3[) 8ɹG(gӔ%\?_" KP{.?{Z_]$ƴm"N1z i ҨIoyW>4=>aSQ2 B:EW[׋x {>|YG)(zRާ(7* QHahNȂFnoe0%;qW|%tԝH&( B>yظGB\F{+czh~w\ǘcSv TVF?>VF.ʿ&Y#7CWϝ*%y)tL ` i i!/ū)VM:7>ՕbLW3Ppl,bb ?O3_]ǽ !W&WQSs|cPB<g9*.Q ?P=19>?MeY-;-;!;dqCRQY\OXc$E7$ wǻ4V!S{p}yQgF{=j^N=(|δPTڝ1/6"[µ\VDB&Ww{TWYJ"L1mS4)tn@~uG9jrI|V=4d(vyLAsR^Ɛι;D{Ƣq4I =[y}7a꟱KVެd|V>Ӟ_S#x>6n0TZ"J`۝2vOڐKlw—}zkvN^A Qpi[mö=T=e(~NZܽW$w<{GWV8牅@*[B4o2Bx?!"z,kI/aHfY!x^:ChٰzH)iQ7Dg Woء~PaxMdw6*8U/dlU:MASfז}?n֝\`iؼa 9fBTE06y łUCѾIteZng\stT.PĶi7%{-UwN;_+O(Soհuޓ(pP 9 N93x^]6Jd-7Dz렲LN-P5QD߇;7EL,c#K`jƸ W 'x'ڹCvvrC圜O/}>|X]ݣ$i!?Oz坯v,P5A Q()J뿍\Z+paOzUӐ0)G#k"ࢼyfQ:6D%])JZ-Tg<_*spW0"D+]ZˢykB^'_/DhX*t) hߛN'Y)?׃Kb$.a{hh%!pFݦc3K_pzo`Oehfت ͙~p9J4 3-uQn%`=ͰފHTl緬sgce3~:i{{e,l/#u۞5 h귎ctXEU.V %k3f\-a[00Q. IXPLlvH}Jh[$1P"(Jmz4o/>)UCAs{W`ֽSHLmu_h7h?_Z7،\ 66k/ş|/8-D3?)JquJЮ *LkQεwV*-_uU+XiX aRتP!;+j-&7J[<(̊^UѶQ[X\O3usZFh OJRr!U6U; w  /;}% d3ŷ>^AS_EynmtnlQƎRanu:cjF+IЬѭ?#Jd,>c:(}?[&Wt9gb.Jy~\YF(}G)RfR)aZ* K$K In!ţAw;*g]ž6۞+/k+Bޏbd1bcÖ?аCЍ,MnP V(SNR!n_FYH+ׁ尠[-mk#/IkUv;SiTqtA~~ljx3Tv.WGr(u]ǒqk jSRVL>U +"gVI$wN8bbx-ϿA@6Ƒ1n1Q2BX\.FQP\PX߿*]M5?68 *gh uv­8b_ /ږ7UPFoeeLU;b.corv3f>^ͩZhӰ-~\/m!PSGǶa{c'7eµUyK?A50MΧߡ,OQ!(|Zˢ8!i׮1QVE^|YwoEULMnf&W wEYVG/5:6+E5<.dRWI2us ą8jW4? YRy ) apcy>gd'f8q 2OzM^U@j!jۺ9eYy`9U}h<}zdžݪJzE](_*t7@[zB8u+uy+e~ZaAZ!H='fI] l 72EQۄ>Ǭ%"а냘dj}a gVeQʜnpםPnGi4nƢ;+D-tUT"75/)/׹M,f5N?]X$*~.\ص3\kd,кׁK`7o8}g"Zpm,>j#2)A@6:Ɲz#sR~uyו(I^ǭPexj:xJ(`ڏ[L|2rdD GG'iZw!&;]J&m],;ظZf7Gttu=5jE!Rҧ쁒C0M3|ֻ淡QHG;־=E`렲̴lMyNNɝR \W;v[V!12:}x:0h`O5ӯ p0 "Q٩(쾭Z`I88(tZΊ<ݼ% @XYMOkI\p,]ѧuKrޠR)~G˼` 6g{ٽ b}܋₇ZqPb'6oFwe*w98Jl)s9Uk+UtCyWsUnP'wT.tPOθfL~]=\ w(MpCkB nn-ghSqQgӴA{lot˩W.?ڙ \Պk3[s%̠:aǟ<C~s+*; wMk-Bmg+Nn`̼"̯o:Oprpi2}#tqzM*>,*a/ŴR>0 s"V>v{Jux&>: a G lll5'@6૟>9R[y Be3cKAѱ=h [7WڢEys}}fS6[_ݲiݧBc~jsW!eUY]JFE]Tb3*}f%$}CKjbjF_Jq-CT|u~N=ҳp C fmydE~ F,*uՔ &}1>Ykפּ%4bO,S1.V~{]Ԃ+3{d-ppX)=Uȣo:,Ze &7vBO>?Z$?=9ƭѸQ?A(7<[IZIBU:|)梅SHAoyřM-]~~Oѿ9$8%,)_V7ĩK.S2ÞڽBAOH O'&4K2Pg+ #9O ,ڎÒ~{a lt >v O o!Ӛ>:ĺы'S0WW{a (|Wy-T4pI) 8g.̈́0oO.h0ni?q&opie8 _X֑ƚZKJIL=C*'\d?Y{f[x ZT9ǪJJJ=ߠۘP(QH.F^B..D] { L!4 99ѱq;.N`G·vE1zE CLEQ@?:y Q?f/\!4?aO91$P(\UXB+O%(reIf ۴Xa~L!4o7k,*[9ELin?v4/-}'E͐) "Q)003 ]Gz`AB$f&ź!4%Yoٟ6*Y߁d#xbr <u§zpNzBN"j gf3eCQ/ްnu"^` 4m>者+۟d-n1 ?d=<3DQ3_`p1<5-硣mxõZw5w(6'LĹ*P*T'=4X&yW놺u;bVx.Js璉3G_<\y<mnZ@rA\on` :k&׺roxl =8f؟xBXb$=>g^V}gj5cjzj"'*;n(X57T*v`}opUUZ kkU1익tH}Li[}vhuw4=ֳ.T$,(0#n4NJE7ZGF2 )ɀ< -S;1vz$& B:9cUX&yb·ظV"ˑc'ka}>z^^˕>"БϡEhwZT4QwyM@so+5> 5&~m'!tW.R89A@{ Nf!&6ی c^@c46.Z0{C%LX67 (i:nlQ=1X,#jvuZaz, DX\S7 I Z׿zU^``R濆cBUjIҢW$ӣ\ h\S 5rƣv4:}A#Eqs0%}=DwnYGѠtTrmǢPa\A㢤 A8{2'u=vw\o;;[y}~-w7c[H'vt/SaHTCl\qK`'J8^\mokV7܀†_B>ܯV]k J *RiQ+s|mhcpYM\NƂ]ez!)rkQP$U*X*V*_;{6㕰8<"'% r8gZڣ&Bރ*fRzE\,s1QԮ7=(q>75ymzo (3:&{jt/.~s Oa yڶnCU,=qw1Z,&8(v(+F`\rşZSxl#lK(O{UEd˖( M̰@JOPP"JиmsPXxnJi29=ݷɲRd$$<_N{7a,{R#EDYWb_].|=2hXY'@֣ՒJ.JbjOEZL/V5APz@T'}y(*pZ$&Q0Wӯ[M{xQ(C8"qsи >!66:pNdvHjEp|dI|ֻ*5vC9Mrsw~AZ27~#ϊ^w5{ɯ.~tT */.X-N4ny}- _WGɊuZو,zQXD92֥n?EK]1(hU585TbxZDHָOo ݈QS3@%_[vM02GahDAV EoT?.J$KIVK,U'GP6:ILW's.w)[D@tYw=˾Ʊ J>ل*;d2몒:ߤ7ƴ痊<"? Me]G4Z *Gmm/)XTDm˼LJo|{:b<68%>Zz% n N:yY+n7B޳ H=,fV-Ҹ ǝQz^%\P,nV_%'Xݶalɨ7% ;P*go^u5 2 f@0ݯum@` W¿8)19ũL鴢CcƘϿsGb“,%Cᵝ+CPDe(=u&Z6ʵ' B-$꼽R8›݃e=j5/Jm"9kU%E*ݮ)*McQҳ5^ț> 8%^:y?>DaR9bvܥwW#nCbN!MQ =kRI\d-E\}tT~{`X)Rw]ʑ-[l %igwb$ҳOVP3<.V}_McG}c'ߡ乨~k8_X_Vm/T+Z7jDym\Z5⊓v)-o-ik"auSCVZ 5ѺcxbreR?7VGoI!sFxixJ19匎!l޹E:*^bu" gV4Q: lwb HƿpI|wLy=rJz ]k/DZb1;(w)n,z]9Ls)5EY*ZO]'{>Z⍮Ě/#(z' >°4ڍ;qB);Ka, *6fXg48 K--A=TRJFkuXkP淯Y,yZ_ݼ :Ͻ>vz|+bfk%(e{^m|"J}~jA'RN$Pa%^J> & O[OJv<r@ڊއ>G|bun^[pTj?%ZUH]EWJ;0J,a,R^DgвL }jpG$ fXEW'W+* B-1'.MMG3>ɹƖڢzθ\'ױ帿_ؖ#-ܤA.0ǂs*s#՞#Ų"G,+Ԑ͝<>!S_/üVubˎ=gQޮamu`/.%Z!闗$(=IH{L}Ɛa +\?tENv> 8 d^!]ToQ^\)"|UegJEצ(eBJ=aLc<,q838 ]φѬA]ڨY:S,|G_URZ]?im?؇\shȗӕWV|şwoZl؆M%wJ/dL}ٹs'uypzղ  L7Vo{@>'͢O#={v!?0R\EEñXS?\Ja^N^Vrƙʸ\`tkJ3[r}[- {V_#JV ͕Fb!L>]}F1{n*gX'σI9a;Rh|gbqW,c1\E HRk*I?@}?+.a/pX! w: \HYoVBw,WQΆ"7׺@tBn:!ȴL`Τ'v|A/h.^og3ew.竆Lͽ'@Q[=_e\uGB C rr \3zsB]tYqИan'W`Z˔|Ϩ39]+/廃zAZa X.?bK(Q%O J$ߩs 2D \]{S}o/_]fSJ ce<"cbSվx_x5ySeOc+2tETL1򓜜dnaX[i!mAL~z1JqG$sr2ו .XR\ 8`\Yu‰dZcb]Wcg-+fei٨XT4 =\M>W}"cko21 gZ0%a `G{ ;$PRBeB%ϲЕ'QqH/MvT#U=iBz]>= Q7aJ<^b&Q//^lbB fir0IXz3>ZzTs\I+!*]]ih8 [޻*|Jrk=w<C7z:4W3)_1/1k`@+m{O| \þ#}=͆7]Њĝ5y"7@\=zo,@b ( pM[-E.; 6ij]^D%ϥri:B o!m4J,%C׌;y 8g@KjIl/'Oe"qM3]q9DcӋe̴GՎp:^dpQ!bbuϏk~_mĒOP=jMG=o_e]Uۛ B(ѪLnj%V|zB/9 IG"5A>:Gұdh/ +\Û{M#\U2>qigk7X QeLP_NC_XO&9Qnes9n C6r-{ϙc'Ob_ꇭxo+0w1=c!zyF޿q٘oa+wVbW}!Ipب|_A*&&`#XQ 2 i37W+ wNsN&{ sNp_>+k*ttˑh {CX8pgMJoY>1(OK+ZZf|0oroE=ON0{S7wb9.JKY 48-]LQ"ynSHB#}P7d2N}/6gΦAJNZ!KN*KH>[$o-ǬS.O;>n ^; #.9 |,.FHV3Y $ h>9ܘE :|rS?I #G^Jpx@פ%7-5c!$m%mg4W"@[@plJ)3rGy|XnGe"eyA]d,'3R:5:3u`^2ݑ|(a}8q$(Cgq48]3׻æ ׃h7f\_,b\2жe]|(LM,[^!!Ɋ4X]0! &n6J!} Ϭ/:hF1DAb$p0=,O9 ۴}徧,ㆇuDZ"wR\ȪHW_5oXj$50lw(vXCP:\M*[ƏB%Q#x4^zs:celU_'彋MnbbWZH~yV.RN1Ʌv [x C~*:^yBVIHH”ҟ!/?~SC=nD,j 9\L^yBVx8v2J!\d^z)+k1psRNzfv>.-0PzZP18ur3H'  a5/sO"nDW,+HQR}kX7&Z|Z1F֗•r=Ǣ4K C~*BѼ4D#bf<@:aXu X" uLO+)mۍ©(N@Igbͯ{q&g`͗'Z C!HxsT 11֤GS286bpr]9RhsSX\Y1k7I.e }k` 0`?EQH U?ٽ'[."joPbmyXH07ܚ;|5c0N0"ʶ`0F<F)}dt DTrieb!1qT<eیgL n]yK 10ypxVGMįJ36AXHQDR\gaz=҆bgIzF@!t(NB ʟY֜ôkYtJ_C@ ßیs lnd,gZ{w<A8nOB4/Q^Q$pAHX!V$~TZC!##2vZ`tA$$Z 1Ѿǫ7"uC LmmEBY4L둛(@:aŅft\`箟e5KERtfSg{xhWpaj ?T>T2Oյ:ń;ys;E]# ~\ߏޑ=}(h8ųYmM[P7\Q>_FœK CF.& (|I[w=ܿ3IJvǕ#_off慷V`Lׅω$ . C|YcQ0N0r)-J?P_3 >ŬWW`c 9%4 ʷk+s,$) (g$n6& IroYUzb/cxf|oKț @ʞ<}B䣯^:mj{b MWw>y',cNg*w{)[^rG|hGEܿp|} E%&^ɳm t 1xJLļzz"/ Bv8~-e+WiI[H?O tB^zٳ.@:{"+u+3TE˚fI4m{e GeqWn˖F).ʗVxe})*`sp#ǰ0hWYY@s>BDο?'/^*l.b+d_E&\Cr-) C9IINHH'|OTv#qun?VnO4m"iQazF,Gkx-foV]Ln: VQv}+z1jvGDC$^#BN)2VoM؞;n :n, !oAPtwFq//Ya50V#{STH'&$P LÞ®Y5 VT̴@`)O0\U~].Swo WT%S+TD='TS{{'e5Lj$M>$w۰}7G>-ɉcV,@W)\[' В}Iϣ(" uzhaeSS8MzLE0]1pyQ$.EaT>PEXUss+N^drBS'{TRI\ K)^AcJ;s+}&&(}x!7 5kxmfG#:D/ϪkN!t"H0Fx.E_IY'ElvIZbY$<{ uT&W XyY.oWK븲l\[5퓿X!xO /Z) 0vuNkSa 0F0:b7ZC^^uC]os bkƛ=Uȱiߣ@n>i7a]N&gzn"Ë]Ps7@:a Q=رRxiPfEy p8fH¥ w}Չ; $P&]>اomMe[Il!}λ OYVh[os (%V|F`VM\,vEbk[TM]}w ~U 8_D7LuZ_֛'%dI{ Ci vm8(sw//%C?9/ 6#!F26ZϾT7\7~Z~rcH' Q2ǵUzK隻7 `Ux,JvB6w헝GYrS] x\+x)./r[d^1#{yIT1&\8g/ֲv$$ơie |qGyQ9qW;t*KNd:3g@:a a8/ב10 `{ xW~W3j<qŜC_ VQՏ7ݵ]& 4(̋T"Le8R쥎\ ĥ9(d 0FDj,|zC^:aWos (9};p">ظO-<L_[!T@ڽ㽏">1 #|"ŻWk;$H' Q2J$o~܊++xK; 䵕ѝ{_\ʆ8DJ_wONr|LlIVj/{eg_P BBz!Oi"S&udKq|0NHdɱqSA'ӮG)ÏkX[QRgSvCr;M5Dٖ`AQH_^e?I{_/z#Â^@rMcCN!t@% UKjp*^0߽Z$z:j=1l.a!8`/ckbKbyj' <˻yCOBI)HQ/ě칑+9 f}_ˑS` 0F LҾgQHN n Iz{Qܝ3nACÛ+NY+}w_E ~%q ttu7Etok>DGL)0NHdI׼z̓zTD"35 BE)*udPU/y/[C|*6`}?ƓU6\܈'/ڝwvVM'e`غ/ZU<0z=R.>CE x ($Li m AJ}PvmQ!"Zq1eXi;b\s qcYVtY`Y^'^> vF3@9!$zJS`JLFA`_)y-&? [<C!4J :=ߪ~" \;yx.ZnPӲ !wpmި4#gOmi q>; D@.U7ez_xq w:=7>6d wi<]cs1pyɕ X}nii韴nz"]J汞,#WJUQȠ|'0D[RmFgb9oG*(i2R9s%o~S:Y^!3IزORs+\E=,.K@:a a:D>;+ܳȱ߬攱DZϠ)IŤ\p1yziʱʳܖA.kKᰪÞ'?A<$҂44f˂IDG xa!h!=) Ci `[*pdrK}$-+Z$ ]=^BSV.!W)Gbz`<@g@:a @PqH`#(b 'A"R_%kd,-kmY ΏxuMwhzpE1gNa/'@ƥ/yB/z=  (^"snk6Dz?m bntC>𕌧WS;=cױ鮴bЬt{\ev%+Kv×k~X;V (LnڹJF tE^=;(ndr ƿl?! T KLΕ蜊k55үUG4}qoVa4lO0IjHF>N>_(h O/ֲ$Wމ4 a%_|o EB BxLڄcŝd$S$.VpmHٲnsض&ޏx zؾ/Iܯd(|nDW:Κf"of ItW* LuOb)m;*@P;ApuG2Y0qZ|LtafکgeoA8CN$'} 7׊6"`e"ab2Zl3N|9_ ˇϻP'-S!xd2Z, AKtE`Ar˃zx36^֦H\QV6[ @@ `e0!̹i9RҬGEJQJ 4~qk9>>MçY@>~NCw viW)p**e wJD`|+?x1 qS CA\-'dB$K]kF/=#pH1,i;Җy}_ΈDad8ڵZyKIJGh}_ש;14Ý%Z~MLq<>}1:4@qq0~BD%v؃YCr):ɔCIOLDұĂ{9W>}0p!FAخvb3ѲCXTCE's$0Y~b,Y> p@y9;˅MSvy,/}6mߍ*g^LjԞC؄$4uW)o ;aj W' wAGk~I"bјDHUG>GدB`ݧq[)o %CO jy.M)-T!8mp?Rݸ)sz>q[vi.@u*.*ݦlt]pW#S!D ^_05 8B$$&#^i}8((QڛurR; 6}[k~%ֿI)RrLkłedj`5^ [ v>o=h*WΜfDwk> {T_*^˅[:,F7u(%;_V8'WivOߡ̻v}v־y"}QHh3M䕇}S$3d|] u2ή(%mM5l#z}Ǜ0i(UĖi9 j~JRj!evVGO` k; %wX뽕i5\UF˵%ع/-O҅FNxLCTt,Nc'LLUk?#9GJtmopWj8MM h5t/#oə-EY$lu XzU8vCkмr:EaxyzHƕ HY@ dM\$H><RJb0y;r3SI48PeMq~ njW<"Y dwPTwRK3Y-K&FCj ^xQʄxq@ X2*nځ*G"O K1I@Pn=Ǣ>y HpW / -#qO>Nqih`"F>?./&igk7B{ G>wb]ߒ $|H\Q*k6Kx@eNǠFO't^>xD-z3~G~gOW}Vyy1HY\X^#9]乗}R"~wOl%7K%*h*WNDCF+3vI-XZEvsҏˋM׆;*MPu?-CԝScvI=G'd$A f9 rrޥQ|s\^@(p>;k7hkO#F[\~II JIڸۍIV9q_^#AJ6YX}.+p>}l4i(͛.r~ Hy;J xqn_l2 tc5`PFdb0Jl%QX`8c |;K ĨBqx'GҼHռw7,"^^IJ"c ;ftO%DFr䡇OS$ϼ{gM[11@*+ Q'FD qT͗Xr:E+Qpk:A-IJQqV "RR rWD䪑V*R"i,Ne'}=>BwE>]哎zϰ/i_fa,>RKߊH_geZD1XVlپσGk?Xw,ZY6B:J(=_Iؿx2tťxF#\ D]ٖP ޖB=cbo;F[,T29(*u Ϭ ZyxZI^Ŕ< @[Hdũ;ZbzJ nz`_?˄`gxC!gَ5C,Nxjz~yطI 3S s^Ws5x/b!j7% CCQP6j>z˅C~sl޽s0ԥcKix󠡧ƞ-J9Cͺ"p\p,Uu(}>AÉK"%:B$+˥S@(O d@s+U3Fک'dAQ\ML *5L*VBE.JR#_s?$i4xI@MYB!2ҟ È}>6R.~/L7 [7儛tbh#QTHIN0( Gm@;:ttD # G^H֊xCw|'_]Y~'_/OD7>_EB~C5, K'Pb߭QTt ~,;_ mFBpg.E\\@)]>m׷ 7! 1/Of/w~edL`&K®}33GH7 sŖRUTD//ʧHw}%!Nv︊ tm{ΓNwlm)I2v||[B8FbC0Xn;}O<몊&I`NrB0qp{_ TyJI+y2QٍD8S:qgw庆K=]B~ 'IdQpEŞB.\s蓵Vd }(8PrM[G`wN8xќ 1]pnRCr cd*a$]Ҁ|.hS=e,"~{\)o>Ͻ>Tٱ\18>$&&?_趎:HʫӺ޾7°1ٳҭHz#8ʅʿWбھ!#Q3"'9$iԍ%ۓ%%9i\ǴcQ*W銕}znM) 2& tƀ)VP9m!PSȩ@wJS }E"x(r !Uo NŚeC ڢeC@.г+$8fӤ0H,4Mxbgk[f"i&d;s U;_~tr+t禛Z"A<Qqu7X?z~vy kb@waPz X|hIMn4z"1sG=?X-#M"@Mm[AH@sQ@}`֔9K| ]co)O/V*rEWQ?H?A}ҊTIH/m'pG;T8a}=g ǡA,14 HomJm%h/E}\=EՎ(WŪCBw0x,&Fݐ\4{Kx][+hC舒=?@(a\-'k7;pK-/}ʹ^'5s Abo7g&^l8v* xIE,6fs*A/T(+iIJa@"IHt٩}..pIqǙnd޴D9Hn9:xɳb;˴ًĊVK>B.}m {B3c-sihr,z%{`?OIků;Y2hI0n;X< QWkM?f9oj,]|weq\nFMID:IH=)qJRW-ߏM;Ҷbk FyNl 5BW {o9IYxDv-Z}OwEڼl)G8.zH+x*ٲC?#y޳6=2ə\Rγѹ(3٩&1g(֜뤶x' ϼB%g+^~А¼h/ AVCpe8W/Eߩ8vv &aAgyh<?3_u2f=yBIdx*urܜ!Ӯb܌WQnEMωzxnde(O+KDtNND Z>(H8=iD5qufʷfrn*OvRRBt~ Evp;/ 4p:>i v.a/0.kƉWq#X!h{:vZ`ѧkQ {22h? uvƈG⎚e7<6N %qi4f=J^AQldHdT%P AN#)&WQ+e@?pMEQ-mvD>%-ܿ%x"߉h봡ճA)'D {N>Q'H? o<p ba7>)':#<8hL! O$cԻ(v4eG℞tvZ::8q‹1Fc:HR $K>d])W^:t#Ѿt,x5:F/;=JOgZ2ӳaÑO,k'&&6+osPX=eE;`ʈu)Wp9sX!B)ݷ4uc R7T鉠=:Ƅ6[E1qRsg`L{]X9}OW̗mL"`(n2IU݀LBwIFqOb0<&C6p@_uMo \݌3lۑ֪(&tjZ7)VҹA%HD  kCe^şH8 ?oۍfP닛͵'@!ss!^ZU1PX\AӊI*&T@oWw5}[=H"qE0isņ"1Sa'Z`C(tko\۶X/J_/aR,%YmXDĠuGpcn[rKfR{9fx,^(id0V˝w^Ɔ_4jD$% eٹ _T[V^pCU?a P;h n!!"BQQ@ fPY9[T>C * Sk˱~DuTn!gvn|'e_w^ޅuw`e7wD4q|&ѸKKP Mp$Cs ?v~PB(-:G՛i\TbL$2ȹ!8#GO ;Ywݷ7e-DR<ƹZ<hݵdݯ2fle|q;vޏDIVAȐAkP_m`g\[5fѹ;p,uЪbYe/G?  |L|vI!i$܁D#@JOoJo? 6 FHތ?K?}d@B orb"<뇘p}DO5VBꈞV15GSH ] 4^_B̜~ZTh?~~hcľF/d%ĭJQ.;`&\{g?~ _NJ*$T:L/7틸E|]!I,O &] gߌCoG԰5kH:] ا;"zB~5\mڷ ׿oQqK&!ItTr+<1/ |}Er)Ľ=Fu{_Ttl܋V~o-=:U*TD^!.|(>xD\M˦Lk2`Y.G 90݉QE5RT5`6}!&cݮH ,kp`-Rs 3Epޫ /-"038>|cJLPL#{b'?j|i9SSi!2F ffspUl$Q~dL?99Z2:P-]>XUbǾo#9&?=|!bD?XKt>wvMzmS؞rY("qJ!ǤAaGr|a(c 24^E֜;9[0G<;$R,7 <2ҌdQ+\{Ydty&."8ֺݰ<3.((l/ 6uL bi,stwo! #{E:\̓L%]및-j/Bb}}<[2 $ I` iC\ Q@eHX]sW_CQ|s}@g( ivi/keCg1"2G*IU.X%afQGD]}{S!@kwȈp/*DcfxRDQZ+ʲZS dO WdˌIe%hQ7~zJZV߮V@s;;P ƕ\BA+Xtww·w ">OK"\z*h'n.H i}/?@ WT &\-qF 4uGD _uL]Liä<_21p_ʍ#cI瑸IiX♴T[BRbSoL dKg6EH>W_! (JAuZVю_I{6٥  3 fSk@s\ M2k v|Y$aH] <'x!'|!6b4,c. 1.$(wSy!Bvt+q0Z v!W,^뱏˸ܪ8Fy! #s @:Q̬VRd*oiayhiҴ[KqreQotT/_ q$ۊyJ<Pyq:wZ( +gk&EZ&{w 1p`E{Vk4ɗ*ɧ%JwH=%4ZǶo}퉲7OPϋxɵ\! ! /F~_CP3k^7]=A%$׺{Di\DXg 8]×]aYMr <}UGYn#=Gc 2'u#KY2%WO .]LYRjAv%ƻu9dz-"zJ5 ExbpX1R>%׊U]z%PI؇C_^`^qeS- YN<9!-enKpOD/PXIjUFf" 4qv(CUaXYb>E4O>\}yFK9{͈}s]*!i$ YO҈y+$zre,!)-ϟ\N,dK9M=Z|k4.g)>% zqB֯=ʰ;XKݣ".C;ht4ݥi[dz%x&G*(#.U/_rYgza8y7Q=@Gb7}n{ ѼJ>H+|I /AzBCo]N ޳d],'3yN+24_$hHXU@< K "8`ͽ.gͺ+%8Ξ$W͵J:Gk)/ uOWI;Hx!2g̳ҹ/C2I  1 ec'MXо@q=;ƯcH3,==y)zHC-%X\t=&qt ۶Ht3ܐV$aⷊJ@nu1ay7o_IƧxRQ<qrSFB:@NxӜ Pݣ+P5>ӉE#rM ե9HhC;+fUz*oٱ.4Ҏkեo{xޅ Vb vmR _,^RR9 b^pK=@|A97bSgHܴBƖlz>ˡI)5 4*.%먡,B̖lIkH"qH:IGv늉#j@UHHh%n<7 9qhRI0L,L|Fv"]HY*S3ҦkF_ֺ^D'y. `(WՃXmG?] ߿Ǿ.+eb)әP^W[u!#s * {9`ώJE7ioCӝed; ?S ! 1E n$ψʍܭX :V@)gfLd1ȶұh'1x= _e³PiYcƩ]Zh~QKH?C*Nv 'FB5vi 9]5 wЀtOF̲ Zj'w׺4.!)빶KgtɾőaHK":D[ދ #zC8bUz!;-ay݄S풞%"e`vu{o !vk]K? ?t!8ia x}#CMa?jy!Lʹ97߿/%h_0~d# cį35*2F%(  /hy;!׸谿ó~ճٗ <&N{tf@=@;z^f'"~Ľ=QcKjxD0ܛD-?'.i0Z GW8)7׸q Jw0šC`ZԈ}ɓ,"BI;{H?D152Ntojdp뤣eǥwTɢHS>c_k\JcJGҡ߭= qs;o@*<).avG켾3[0~ڗ{u<b=繱iAv"<=X U7śfreL-s/"5.% L\]dk]JH+YCGgOZsR0 OSb&VO9ԝM{\NbHp-,9+ġbh"[7׼螀g:v><'( AoKc4n^ɧ}:<ztp 3f=sGvByvK HKfq9ٳIb+t8Yo#ytxji3F2w{KN^tO Juh=_3gҳ@|<1 Mie2LClITX.~;wުY"/d*bb~_[c-G<@&WboҠwC[ȴ G<3aYuxJ|K ^l';w|y4"Sx^U1<LoIAɶrx=\Z'r}rqvi渷GۮzFIQ` YWc6q{ GV6~d>0"xxG9pzSNr 8}sΛW-+SXr:8zs_7N W%c"ΉfBT~tҵ)쉕߷QԇfZ1kҼDyWj]o4amقKߪ߬ xy?P2P@jw.J ^5UB 'GPﺴXP_4I7H%dFGtvX o EIzny٧sZduIsWKYPjⷢ6Je{/yG&Vrmڣ%,[bdAut/}, ]u-pNlOY/u{^wy(4EpQ500J!7NNqJv+}ku@Q(@nK9^4Gds :TYcprhl+;e[غ>ltS;"$yF"E{vNp:'̖OSmE_WY{lnh)y˘k'+=*uW~1^}?OcZ:bCA`O}er jum44+4}4TcJju +¥ Asutؾ{MW~?*>ӛey8 $Vz;]Pc&(|(>/ɖ䇂-Øy <J7t}姟=l C퀟h+4Rzy1~]߫]phtHJ&<P`ѡt"'5uMkBs߮ޔ->{X?]/Zfs'C&e=Vcm6QzYCN#@iTc*qClΛ8>ʸt>.a tyNN'OmzTNϠ |r+ァ)ƃW:VIHc^:L_:lIvۀa1Gϋ(m( n -^IW[D\{bh> \G)Y!C|(a$CslZ_~V"A-=xtWj^6_ִ=LLe ͧnd4s3"JZ}Uj:h;{V ۏTޡXGK$yH篲 DT I G?ڕG'tߴbUwѼQ{d}k>tøEp=(D|y뤬Tl|qwf1sn({J4:ԡ(32PukV[5@:VMW7 m>~i; eggZ['JjH}ݒu^om`?썱v嶢KIRQ?PCdTZk/<Ԍ~4$;eߦJmM7DXeqTQl]V?(mF -vIJ!tH4xC!zND=~FW\RhY'oٟPؑ-}埶n= J]FܙR mDaru/n-6Nۙ`FY=]Sgz hMTke'?#t3>NHGHי6`T[=w@@>a|mpdKχ ޕP6iϟʾP߰ʧ >`ӽF@lmyuŷCۨg>"htNA\E֩YL%L}$6Y i}>Ê=)(8=ɴG顱uۼBS" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@" RDH)"E@B4 IENDB`}DyK _Toc366438825}DyK _Toc366438825}DyK _Toc366438826}DyK _Toc366438826}DyK _Toc366438827}DyK _Toc366438827}DyK _Toc366438828}DyK _Toc366438828}DyK _Toc366438829}DyK _Toc366438829}DyK _Toc366438830}DyK _Toc366438830}DyK _Toc366438831}DyK _Toc366438831}DyK _Toc366438832}DyK _Toc366438832}DyK _Toc366438833}DyK _Toc366438833}DyK _Toc366438834}DyK _Toc366438834}DyK _Toc366438835}DyK _Toc366438835}DyK _Toc366438836}DyK _Toc366438836}DyK _Toc366438837}DyK _Toc366438837}DyK _Toc366438838}DyK _Toc366438838}DyK _Toc366438839}DyK _Toc366438839}DyK _Toc366438840}DyK _Toc366438840}DyK _Toc366438841}DyK _Toc366438841DyK _What_training_doesDyK yK Phttp://www.citiprogram.org/yX;H,]ą'cDyK yK phttp://phrp.nihtraining.com/users/login.phpyX;H,]ą'c$$If!vh#v #vU:V l4 t0m6+,55/  /  f4ytrT$$If!vh#v #v#v#vz:V l4 t0m6+,55 5q5/ / / f4ytrT$$If!vh#v #v#v#vz:V l4{ t0m6+,55 5q5/ / / f4ytrT^4 xxx02 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XVx_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH Z@Z K Heading 1$<@&5CJ KH OJQJ\^JaJ \@\ 1K Heading 2$<@& 56CJOJQJ\]^JaJV@V Om Heading 3$<@&5CJOJQJ\^JaJDA D Default Paragraph FontRi@R  Table Normal4 l4a (k (No List 6B@6 '6> U List Bullet 2  & F>7@>  List Bullet 3  & FHT"H BS Block Texthhxx]h^h<P2< <7 Body Text 2 dxNoAN BSBlock Text CharCJ_HaJmH sH tH 6U`Q6 a&c0 Hyperlink >*B*ph4@b4 "1Header  !4 r4 1Footer  !.). 1 Page NumberF8F bg List Bullet 4 & F<<bob ZDefault 7$8$H$-B*CJOJQJ^J_HaJmH phsH tH 828 LList 2^`B'`B _CComment ReferenceCJaJ<@< _C Comment TextCJaJ@j@@ _CComment Subject5\H@H _C Balloon TextCJOJQJ^JaJ>@> 58 Footnote Text CJaJ@&`@ 58Footnote ReferenceH*Fo!F  Header CharCJ_HaJmH sH tH 2@2 YpTOC 2 #^CJFoAF {ml Char Char1CJ_HaJmH sH tH && /pTOC 1%2@2 YpTOC 3 &^CJ<oq< *B*phf@f vE List Paragraph+d^m$CJOJPJQJ^JaJl Al L)p TOC Heading,$d@& %B*CJKHOJPJQJ^JaJph6_<o< URs SOP Leader5CJOJQJ<O< URsSOP Name.OJQJ^JaJVOV URsSOP Table Header/$a$CJOJQJ^JaJ>O> URsSOP Table Entry0CJToT $Heading 2 Char 56CJOJQJ\]^JaJN"N c9Question#2 & F 2 hx^020 c9Answer 3 & FPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] .7 | ;| || 8   Gu"'/@39>d?? "#$%&'()*+,./124568;P.=>????!-0379:<=@XYy9i   .s%OkmnpRnpqs[wyz|%ACDFf&C_abdn B}7 X%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕ̕XXXi!@ @H 0(  0(  B S  ? _Toc366438825 _Toc366438826 _Toc366438827 _Toc366438828 _Toc366438829 _Toc366438830 _Toc366438831 _Toc366438832 _Toc366438833 _Toc366438834 _Toc366438835 _Toc366438836 _Toc366438837 _Toc366438838 _Toc366438839 _Toc366438840 _Toc366438841 X C;"&L).0x13O57   AK"&n).01357%'66666666677-H 66666666677333-@.^i R]EP*,5WXXii 6,6Q6666666666666;7`7d7777777-@xy89-.$%ef%&.^i R]EP*,5WXXii 6,6Q6666666666666;7`7d7777777r` xJm& f}X bW"s Yv8:PF(e&"Nn $%:CaY&GlV.&LZPI&QFjLZlx ?2 =m4pOX|WmX؞nneZ\oF6)Hq"0xD)rkq8:4vr nx/\23Ry0` ^`OJQJo( 88^8`OJQJo( ^`OJQJo(h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hH ^`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`o(hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.^`o(()^`o(()h PL^P`LhH.h80^8`0OJPJQJ^Jo(" h^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.h80^8`0OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hH ^`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH. ^`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh ^`o(hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH. h^h`hH. 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH. hu$ ^$ `3*G,56\]CJOJQJsHtH^JaJ_H4*789:;<>*@EHH*KHS*TXY([o(hH Appendix B-h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.80^8`0OJPJQJ^Jo(" ^`OJQJ^Jo(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoP^P`OJQJo(hH hh^h`hH) ^`hH) 88^8`hH) ^`hH() ^`hH() pp^p`hH()   ^ `hH. @ @ ^@ `hH.   ^ `hH.2 02 ^2 `0o(Q.88^8`o(.88^8`o()^`o(()^`o(()pp^p`o(()  ^ `o(.@ @ ^@ `o(.  ^ `o(.h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`B*OJQJo(phhHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHvr&QFjhRe&"lVnx                       fWzE r                                                                                                                  R                                                              \i        r          ȿ0      a53g759H/3g7|53g75>m#59,+59 .3g7H/3g7v;eR:<eRQAeR?D3g7b\ReReRZZG_eREH.i3g7[peR}u59vzkj U?ez%8I^r=/dOl~w<!!8 I& / pR 99 .a f u Ap p R 6 t( }n *p x-A~AyCRjsNAY`h7QK] U!)BYX _f iBkD$pMz)'wJuo(e :E 7!U!"` "KC"["m"I{"$Q$1%G%aU%Y&2J2B3>3K32g3V506=y7~71858_x8y89c9:DX:Z:d:Q ;R;wt<}=Yp> ?b&?)?=@]AlA3;Aa;A KAgkA7B;B6CBwNBC ,CDC_C?aDFE1F;F WF_FrG!H-H;;HCH/I6I\I(J|JK`KcLlLAM5IMNO$WO~OPQ4PjP7Q!iQN.R-YRGS,TBT"PT,U)VQWVWxY:YDYhkYqYZ;ZDgZ[["[13[<[|[_2\7X\t4]I]K^ ^6^J^\^d^u^6_K_/1_[_`JPaMdahaca&cXdelejff8fgg3g>hiijkwk7l7l{mlKmem{rm%n 9npn8o%p!p)p@pqqAFqQq\qgqes(sURsZsDtbtuJvvv3vIvSv_vww8w8GwtTwmwqwuwizx{x5yjya{{{Z{O|(~F~ LiR.cXel6HHNOmtES.<7+M!Vd(G>$0*CnM0eir )+OHW*^V1#i+>SQBJ`avS >LO^"7Tr){ ,Q@j"o8Y+;7_g~R^t@)zVrJR, Ak+ahf AP@WD TBJ*6P^-GIKL+T8O Xm*7 !YV*:\#vEXWyv{1bYyv@Gt UC>2sy8$4INZ1fj}DMx|62 f 4Zk!L)ALOvao%9 T;a7:<A#MK\-cshZ(Iv05ZW^g<;;CGbZl#h<JTq7UV|[i{{ 5raUR -T1jn E2]Z0jO dnW-G05~ Ckig\uZ"u"+2P.N)2S Gd!#>n6SA8[xI{V'Z,MBSKn(ybdu0Q5WW^mx//Lbg{Bt0|Jb`5]!0 BB4%6o@M>bn#s#$e RCYt66@'''' 7H@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.@CalibriqNNFPLJ+TimesNewRomanTimes New Roman5. .[`)Tahoma7@Cambria?= *Cx Courier New;WingdingsA$BCambria Math"h2"Hg4..c..c!82466 3qHP K2! xx : RP-103 - INVESTIGATOR MANUALHuron HRPP ToolKitHuron, HRPP, SOPJeffrey A. Cooper, MD, MMMutsa                          Oh+'0\$    $ 0<DLT : RP-103 - INVESTIGATOR MANUALHuron HRPP ToolKitJeffrey A. Cooper, MD, MMMHuron, HRPP, SOP2009-2012 Huron Consulting Services, LLC. Use and distribution subject to End User License Agreement at http://www.huronconsultinggroup.com/SOPNormalutsa5Microsoft Office Word@_@,+@R#@w..՜.+,D՜.+,T px   3 Stuart Horowitz, PhD, MBA, CHRC Huron Consulting Group, Inc.c6 : RP-103 - INVESTIGATOR MANUAL Title 8@ _PID_HLINKSAxz{o,http://phrp.nihtraining.com/users/login.phpx4lhttp://www.citiprogram.org/f]i_What_training_does>b_Toc366438841>\_Toc366438840>V_Toc366438839>P_Toc366438838>J_Toc366438837>D_Toc366438836>>_Toc366438835>8_Toc366438834>2_Toc366438833>,_Toc366438832>&_Toc366438831> _Toc366438830>_Toc366438829>_Toc366438828>_Toc366438827>_Toc366438826>_Toc366438825  !"#$%&'()*+,-./0123456789:;<=>@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~ Root Entry FData ?1TableWordDocument|SummaryInformation(DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q